Target intelligence / Profile preview

5-oxoprolinase (OPLAH)

Target
OPLAH
Molecular classification
Enzyme, Hydrolase (acting on carbon-nitrogen bonds other than peptide bonds, specifically in cyclic amides)
01

Overview

5-oxoprolinase is a cytoplasmic ATP-dependent enzyme essential for converting 5-oxo-L-proline to L-glutamate, operating as part of the gamma-glutamyl cycle that maintains glutathione homeostasis and amino acid metabolism[4][5][6][8]. Deficiency results in excess 5-oxoproline (5-oxoprolinuria), a rare inherited metabolic disorder with diverse systemic and neurological symptoms, highlighting the enzyme's importance in cellular redox balance and metabolic stress response[8].

Other names
5-oxo-L-prolinase5-oxo-L-proline amidohydrolase (ATP-hydrolyzing)5-OPaseOPLAHpyroglutamasepyroglutamate hydrolaseL-pyroglutamate hydrolase
02

Mechanism of action

For inhibitors, competitive inhibition of the enzyme’s ATP-dependent hydrolytic activity, resulting in accumulation of 5-oxoproline and interfering with glutathione recycling

03

Biological functions

Glutathione metabolism (gamma-glutamyl cycle)Amino acid metabolismATP hydrolysisMetabolite damage control/repair
04

Disease associations

Inherited metabolic disorder (5-oxoprolinase deficiency, a form of 5-oxoprolinuria)Potential involvement in oxidative stress and glutathione deficiency-related conditions
05

Safety considerations

Loss-of-function causes 5-oxoprolinuriaNeurological symptomsMetabolic acidosisKidney stonesEnterocolitisAnemiaMicrocephalyPotential mental retardationEmphasizes risks with any therapeutic manipulation
06

Interacting drugs

L-2-imidazolidone-4-carboxylate (experimental inhibitor)
07

Biomarkers

Elevated urinary or plasma 5-oxoproline (pyroglutamic acid)

Beyond the preview

Go deeper on 5-oxoprolinase (OPLAH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5-oxoprolinase (OPLAH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call